Handelsbanken Fonder’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $20.1M | Buy |
93,236
+10,510
| +13% | +$2.01M | 0.06% | 268 |
|
|
2026
Q1 | $15.2M | Sell |
82,726
-1,502
| -2% | -$277K | 0.05% | 290 |
|
|
2025
Q4 | $14.8M | Sell |
84,228
-15,088
| -15% | -$2.46M | 0.04% | 318 |
|
|
2025
Q3 | $13.9M | Buy |
99,316
+1,715
| +2% | +$232K | 0.04% | 327 |
|
|
2025
Q2 | $12.3M | Buy |
97,601
+17,347
| +22% | +$2.16M | 0.04% | 327 |
|
|
2025
Q1 | $11M | Sell |
80,254
-1,681
| -2% | -$240K | 0.05% | 323 |
|
|
2024
Q4 | $12.5M | Buy |
81,935
+13,433
| +20% | +$2.27M | 0.05% | 324 |
|
|
2024
Q3 | $13.3M | Buy |
68,502
+1,296
| +2% | +$271K | 0.05% | 306 |
|
|
2024
Q2 | $15.6M | Buy |
67,206
+3,146
| +5% | +$684K | 0.07% | 255 |
|
|
2024
Q1 | $13.8M | Buy |
64,060
+6,527
| +11% | +$1.53M | 0.06% | 288 |
|
|
2023
Q4 | $14.9M | Sell |
57,533
-18,231
| -24% | -$4.48M | 0.07% | 257 |
|
|
2023
Q3 | $19.5M | Buy |
75,764
+974
| +1% | +$261K | 0.11% | 196 |
|
|
2023
Q2 | $21.3M | Buy |
74,790
+5,555
| +8% | +$1.65M | 0.11% | 199 |
|
|
2023
Q1 | $19.2M | Buy |
69,235
+3,013
| +5% | +$834K | 0.11% | 208 |
|
|
2022
Q4 | $18.3M | Sell |
66,222
-12,177
| -16% | -$3.44M | 0.12% | 210 |
|
|
2022
Q3 | $20.9M | Sell |
78,399
-1,586
| -2% | -$337K | 0.14% | 175 |
|
|
2022
Q2 | $16.3M | Buy |
79,985
+37,671
| +89% | +$7.7M | 0.11% | 202 |
|
|
2022
Q1 | $8.91M | Sell |
42,314
-23,372
| -36% | -$5.08M | 0.05% | 344 |
|
|
2021
Q4 | $15.8M | Sell |
65,686
-21,897
| -25% | -$5.63M | 0.08% | 250 |
|
|
2021
Q3 | $24.8M | Sell |
87,583
-8,757
| -9% | -$2.87M | 0.13% | 173 |
|
|
2021
Q2 | $33.4M | Buy |
96,340
+9,134
| +10% | +$2.77M | 0.17% | 128 |
|
|
2021
Q1 | $24.4M | Buy |
87,206
+25,525
| +41% | +$6.88M | 0.14% | 154 |
|
|
2020
Q4 | $15.1M | Sell |
61,681
-2,698
| -4% | -$696K | 0.09% | 217 |
|
|
2020
Q3 | $18.3M | Sell |
64,379
-844
| -1% | -$235K | 0.13% | 158 |
|
|
2020
Q2 | $17.4M | Buy |
65,223
+25,851
| +66% | +$7.77M | 0.15% | 146 |
|
|
2020
Q1 | $12.5M | Sell |
39,372
-4,500
| -10% | -$1.37M | 0.27% | 100 |
|
|
2019
Q4 | $13M | Buy |
+43,872
| New | +$12.2M | 0.23% | 116 |
|
|
2017
Q1 | – | Sell |
-4,800
| Closed | -$1.36M | – | 169 |
|
|
2016
Q4 | $1.36M | Sell |
4,800
-3,700
| -44% | -$1.1M | 0.04% | 140 |
|
|
2016
Q3 | $2.66M | Sell |
8,500
-1,530
| -15% | -$453K | 0.08% | 136 |
|
|
2016
Q2 | $2.42M | Sell |
10,030
-5,000
| -33% | -$1.32M | 0.1% | 112 |
|
|
2016
Q1 | $3.91M | Sell |
15,030
-24,943
| -62% | -$6.59M | 0.17% | 106 |
|
|
2015
Q4 | $12.2M | Buy |
+39,973
| New | +$11.5M | 0.24% | 115 |
|
Other funds holding BIIB
Handelsbanken Fonder's BIIB Position: Q2 2026 in Review
Handelsbanken Fonder increased its Biogen (BIIB) stake by 13% in Q2 2026, buying an estimated $2.01M and bringing the position to 93,236 shares worth $20.1M. The position accounts for 0.06% of the portfolio, ranked #268.
Handelsbanken Fonder first reported a position in BIIB in Q4 2015 and has held it in 32 quarters since. The position peaked at $33.4M in Q2 2021. 679 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Handelsbanken Fonder held 93,236 shares of Biogen worth $20.1M as of Q2 2026.
- Handelsbanken Fonder bought 10,510 Biogen shares in Q2 2026, an estimated $2.01M.
- Biogen made up 0.06% of Handelsbanken Fonder's portfolio in Q2 2026, its #268 holding.
- Handelsbanken Fonder first reported a position in Biogen in Q4 2015 and has held it in 32 quarters since.
- Handelsbanken Fonder's Biogen position peaked at $33.4M in Q2 2021.
- 679 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.